{"entity":{"type":"insider","cik":"0001867418","url":"/insider/0001867418","json_url":"/insider/0001867418.json","name":"Barton Russell","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":6,"first":"2024-01-19","last":"2026-01-23","span_basis":"filed_date"},"name_variants":[{"name":"Barton Russell","source":"filing","n_filings":6,"first_seen":"2024-01-19","last_seen":"2026-01-23"}],"transactions":[{"id":5786982,"accession":"0001628280-26-003344","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-26-003344","line_url":"/filing/0001628280-26-003344#line-2","is_derivative":false,"issuer_cik":"0001576885","issuer_name":"Acumen Pharmaceuticals, Inc.","issuer_ticker":"ABOS","issuer_name_source":null,"issuer_url":"/issuer/0001576885","owner_cik":"0001867418","owner_name":"Barton Russell","owner_display_name":"Barton Russell","owner_url":"/insider/0001867418","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":462.0,"shares_display":"462","price_per_share":1.84,"price_display":"1.84","price_state":"stated","total_value":850.08,"total_display":"850.08","total_whole":"850","shares_owned_after":205092.0,"shares_owned_after_display":"205,092","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-22","filed_date":"2026-01-23","scope":"insider"},{"id":5786980,"accession":"0001628280-26-003344","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-003344","line_url":"/filing/0001628280-26-003344#line-1","is_derivative":false,"issuer_cik":"0001576885","issuer_name":"Acumen Pharmaceuticals, Inc.","issuer_ticker":"ABOS","issuer_name_source":null,"issuer_url":"/issuer/0001576885","owner_cik":"0001867418","owner_name":"Barton Russell","owner_display_name":"Barton Russell","owner_url":"/insider/0001867418","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2315.0,"shares_display":"2,315","price_per_share":1.806,"price_display":"1.81","price_state":"stated","total_value":4180.89,"total_display":"4,180.89","total_whole":"4,181","shares_owned_after":205554.0,"shares_owned_after_display":"205,554","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-21","filed_date":"2026-01-23","scope":"insider"},{"id":6023112,"accession":"0001628280-26-001897","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-001897","line_url":"/filing/0001628280-26-001897#line-1","is_derivative":false,"issuer_cik":"0001576885","issuer_name":"Acumen Pharmaceuticals, Inc.","issuer_ticker":"ABOS","issuer_name_source":null,"issuer_url":"/issuer/0001576885","owner_cik":"0001867418","owner_name":"Barton Russell","owner_display_name":"Barton Russell","owner_url":"/insider/0001867418","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3530.0,"shares_display":"3,530","price_per_share":1.8588,"price_display":"1.86","price_state":"stated","total_value":6561.564,"total_display":"6,561.56","total_whole":"6,562","shares_owned_after":123269.0,"shares_owned_after_display":"123,269","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-08","filed_date":"2026-01-12","scope":"insider"},{"id":6076914,"accession":"0001628280-26-001261","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-26-001261","line_url":"/filing/0001628280-26-001261#line-3","is_derivative":false,"issuer_cik":"0001576885","issuer_name":"Acumen Pharmaceuticals, Inc.","issuer_ticker":"ABOS","issuer_name_source":null,"issuer_url":"/issuer/0001576885","owner_cik":"0001867418","owner_name":"Barton Russell","owner_display_name":"Barton Russell","owner_url":"/insider/0001867418","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1700.0,"shares_display":"1,700","price_per_share":1.9871,"price_display":"1.99","price_state":"stated","total_value":3378.07,"total_display":"3,378.07","total_whole":"3,378","shares_owned_after":126799.0,"shares_owned_after_display":"126,799","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-07","filed_date":"2026-01-07","scope":"insider"},{"id":6076912,"accession":"0001628280-26-001261","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-26-001261","line_url":"/filing/0001628280-26-001261#line-2","is_derivative":false,"issuer_cik":"0001576885","issuer_name":"Acumen Pharmaceuticals, Inc.","issuer_ticker":"ABOS","issuer_name_source":null,"issuer_url":"/issuer/0001576885","owner_cik":"0001867418","owner_name":"Barton Russell","owner_display_name":"Barton Russell","owner_url":"/insider/0001867418","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3618.0,"shares_display":"3,618","price_per_share":1.9664,"price_display":"1.97","price_state":"stated","total_value":7114.4352,"total_display":"7,114.44","total_whole":"7,114","shares_owned_after":128499.0,"shares_owned_after_display":"128,499","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-06","filed_date":"2026-01-07","scope":"insider"},{"id":6076910,"accession":"0001628280-26-001261","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-001261","line_url":"/filing/0001628280-26-001261#line-1","is_derivative":false,"issuer_cik":"0001576885","issuer_name":"Acumen Pharmaceuticals, Inc.","issuer_ticker":"ABOS","issuer_name_source":null,"issuer_url":"/issuer/0001576885","owner_cik":"0001867418","owner_name":"Barton Russell","owner_display_name":"Barton Russell","owner_url":"/insider/0001867418","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":1.9581,"price_display":"1.96","price_state":"stated","total_value":7832.4,"total_display":"7,832.40","total_whole":"7,832","shares_owned_after":132117.0,"shares_owned_after_display":"132,117","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-07","scope":"insider"},{"id":5171555,"accession":"0001576885-25-000031","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001576885-25-000031","line_url":"/filing/0001576885-25-000031#line-1","is_derivative":false,"issuer_cik":"0001576885","issuer_name":"Acumen Pharmaceuticals, Inc.","issuer_ticker":"ABOS","issuer_name_source":null,"issuer_url":"/issuer/0001576885","owner_cik":"0001867418","owner_name":"Barton Russell","owner_display_name":"Barton Russell","owner_url":"/insider/0001867418","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2914.0,"shares_display":"2,914","price_per_share":1.6102,"price_display":"1.61","price_state":"stated","total_value":4692.1228,"total_display":"4,692.12","total_whole":"4,692","shares_owned_after":136117.0,"shares_owned_after_display":"136,117","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-21","filed_date":"2025-01-23","scope":"insider"},{"id":4652020,"accession":"0001576885-25-000013","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001576885-25-000013","line_url":"/filing/0001576885-25-000013#line-1","is_derivative":false,"issuer_cik":"0001576885","issuer_name":"Acumen Pharmaceuticals, Inc.","issuer_ticker":"ABOS","issuer_name_source":null,"issuer_url":"/issuer/0001576885","owner_cik":"0001867418","owner_name":"Barton Russell","owner_display_name":"Barton Russell","owner_url":"/insider/0001867418","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7636.0,"shares_display":"7,636","price_per_share":1.8629,"price_display":"1.86","price_state":"stated","total_value":14225.1044,"total_display":"14,225.10","total_whole":"14,225","shares_owned_after":89231.0,"shares_owned_after_display":"89,231","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-03","filed_date":"2025-01-07","scope":"insider"},{"id":2063086,"accession":"0001576885-24-000024","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001576885-24-000024","line_url":"/filing/0001576885-24-000024#line-1","is_derivative":false,"issuer_cik":"0001576885","issuer_name":"Acumen Pharmaceuticals, Inc.","issuer_ticker":"ABOS","issuer_name_source":null,"issuer_url":"/issuer/0001576885","owner_cik":"0001867418","owner_name":"Barton Russell","owner_display_name":"Barton Russell","owner_url":"/insider/0001867418","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2833.0,"shares_display":"2,833","price_per_share":3.7258,"price_display":"3.73","price_state":"stated","total_value":10555.1914,"total_display":"10,555.19","total_whole":"10,555","shares_owned_after":96867.0,"shares_owned_after_display":"96,867","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-18","filed_date":"2024-01-19","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":9,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001576885","name":"Acumen Pharmaceuticals, Inc.","url":"/issuer/0001576885","role":"Officer (Chief Operating Officer)","n_filings":6,"first_seen":"2024-01-19","last_seen":"2026-01-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001867418","retrieved_at":"2026-08-26T23:40:22+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}